These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31606242)

  • 1. Susceptibility evolution to antibiotics of Enterobacter cloacae, Morganella morganii, Klebsiella aerogenes and Citrobacter freundii involved in urinary tract infections: an 11-year epidemiological surveillance study.
    Jiménez-Guerra G; Borrego-Jiménez J; Gutiérrez-Soto B; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Apr; 38(4):166-169. PubMed ID: 31606242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Resistances of Enterobacteriaceae with Chromosomal Ampc in Urine Cultures: Review and Experience of a Spanish Hospital.
    Rodríguez-Guerrero E; Cabello HR; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
    Lu B; Wong M; Ha D; Bounthavong M; Banaei N; Deresinski S; Diep C
    J Antimicrob Chemother; 2023 Apr; 78(4):1009-1014. PubMed ID: 36879495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens.
    Kao CC; Liu MF; Lin CF; Huang YC; Liu PY; Chang CW; Shi ZY
    J Microbiol Immunol Infect; 2010 Jun; 43(3):180-7. PubMed ID: 21291844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens.
    Park YJ; Yu JK; Lee S; Park JJ; Oh EJ
    Ann Clin Lab Sci; 2007; 37(1):75-8. PubMed ID: 17311873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae.
    Akata K; Muratani T; Yatera K; Naito K; Noguchi S; Yamasaki K; Kawanami T; Kido T; Mukae H
    PLoS One; 2019; 14(7):e0218589. PubMed ID: 31283769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ampC derepression on cefepime MIC in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
    Kohlmann R; Bähr T; Gatermann SG
    Clin Microbiol Infect; 2019 Sep; 25(9):1158.e1-1158.e4. PubMed ID: 31128286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020-2022.
    Boattini M; Bianco G; Llorente LI; Acero LA; Nunes D; Seruca M; Mendes VS; Almeida A; Bastos P; Rodríguez-Villodres Á; Gascón AG; Halperin AV; Cantón R; Escartín MNL; González-López JJ; Floch P; Massip C; Chainier D; Barraud O; Dortet L; Cuzon G; Zancanaro C; Mizrahi A; Schade R; Rasmussen AN; Schønning K; Hamprecht A; Schaffarczyk L; Glöckner S; Rödel J; Kristóf K; Balonyi Á; Mancini S; Quiblier C; Fasciana T; Giammanco A; Paglietti B; Rubino S; Budimir A; Bedenić B; Rubic Z; Marinović J; Gartzonika K; Christaki E; Mavromanolaki VE; Maraki S; Yalçın TY; Azap ÖK; Licker M; Musuroi C; Talapan D; Vrancianu CO; Comini S; Zalas-Więcek P; Michalska A; Cavallo R; Melo Cristino J; Costa C
    Int J Antimicrob Agents; 2024 May; 63(5):107115. PubMed ID: 38367844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
    Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of imipenem against 1386 clinical isolates.
    Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
    Kays MB
    Pharmacotherapy; 1999 Dec; 19(12):1392-9. PubMed ID: 10600088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial resistance monitoring of gram-negative bacilli isolated from 15 teaching hospitals in 2014 in China].
    Wang Q; Wang H; Yu Y; Xu X; Sun Z; Lu J; Yang B; Zhang L; Hu Z; Feng X; Xu Y; Ni Y; Mei Y; Liao K; Ji P; Chu Y
    Zhonghua Nei Ke Za Zhi; 2015 Oct; 54(10):837-45. PubMed ID: 26675021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.